Total Payments
$34,147
2024 Payments
$2,761
Companies
53
Transactions
688
Medicare Patients
2,894
Medicare Billing
$343,291
Payment Breakdown by Category
Other$20,293 (59.4%)
Food & Beverage$13,763 (40.3%)
Education$90.92 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,150 | 15 | 56.1% |
| Food and Beverage | $13,763 | 668 | 40.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,143 | 1 | 3.3% |
| Education | $90.92 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $17,516 | 69 | $0 (2019) |
| ABBVIE INC. | $6,630 | 203 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $1,143 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,037 | 67 | $0 (2024) |
| Gilead Sciences, Inc. | $934.59 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $761.22 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $727.10 | 34 | $0 (2024) |
| Celgene Corporation | $395.46 | 19 | $0 (2024) |
| QOL Medical, LLC | $345.16 | 17 | $0 (2024) |
| GENZYME CORPORATION | $323.72 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,761 | 116 | ABBVIE INC. ($476.88) |
| 2023 | $3,343 | 135 | AbbVie Inc. ($882.68) |
| 2022 | $1,639 | 73 | ABBVIE INC. ($451.99) |
| 2021 | $197.48 | 3 | AbbVie Inc. ($96.94) |
| 2020 | $403.08 | 20 | AbbVie Inc. ($194.71) |
| 2019 | $4,148 | 102 | Allergan Inc. ($2,429) |
| 2018 | $7,318 | 115 | Allergan Inc. ($4,548) |
| 2017 | $14,338 | 124 | Allergan Inc. ($10,538) |
All Payment Transactions
688 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Immunology | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $47.11 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.96 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Rare Disease | ||||||
| 10/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Gastroenterology | ||||||
| 09/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 614 | 725 | $268,845 | $75,082 |
| 2022 | 15 | 721 | 871 | $317,934 | $87,501 |
| 2021 | 16 | 782 | 934 | $329,476 | $92,738 |
| 2020 | 15 | 777 | 946 | $302,075 | $87,970 |
Total Patients
2,894
Total Services
3,476
Medicare Billing
$343,291
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 184 | $47,104 | $17,130 | 36.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 58 | 58 | $49,300 | $11,744 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $24,500 | $8,458 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 115 | $16,790 | $7,076 | 42.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 62 | $24,800 | $4,250 | 17.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 22 | 22 | $16,896 | $3,523 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $9,331 | $3,451 | 37.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $10,260 | $3,429 | 33.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 37 | $7,733 | $3,357 | 43.4% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $8,194 | $2,917 | 35.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $15,360 | $2,594 | 16.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $20,000 | $2,330 | 11.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 11 | 13 | $5,850 | $1,458 | 24.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,722 | $1,425 | 30.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $5,600 | $1,357 | 24.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 13 | $2,405 | $583.52 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 172 | $44,032 | $14,483 | 32.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 67 | 70 | $59,500 | $13,475 | 22.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 163 | $34,067 | $12,844 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 55 | $22,330 | $7,980 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 81 | 81 | $17,577 | $5,641 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 91 | $13,286 | $5,621 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $16,100 | $5,289 | 32.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 62 | 65 | $26,000 | $4,300 | 16.5% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $10,260 | $3,503 | 34.1% |
About Dr. Vikram Singh, M.D
Dr. Vikram Singh, M.D is a Gastroenterology healthcare provider based in Glendale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942401807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Singh, M.D has received a total of $34,147 in payments from pharmaceutical and medical device companies, with $2,761 received in 2024. These payments were reported across 688 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,150).
As a Medicare-enrolled provider, Singh has provided services to 2,894 Medicare beneficiaries, totaling 3,476 services with total Medicare billing of $343,291. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Glendale, AZ
- Active Since 05/29/2007
- Last Updated 12/22/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1942401807
Products in Payments
- LINZESS (Drug) $17,067
- Humira (Biological) $1,171
- ESD - Core Endoscopy (Device) $1,143
- VIBERZI (Drug) $777.53
- ZEPOSIA (Drug) $547.13
- DUPIXENT (Biological) $544.21
- TRULANCE (Drug) $482.42
- MAVYRET (Drug) $475.25
- RINVOQ (Biological) $472.08
- XIFAXAN (Drug) $455.85
- STELARA (Biological) $455.60
- Mavyret (Drug) $389.09
- Creon (Drug) $361.99
- ENTYVIO (Biological) $332.20
- SKYRIZI (Biological) $301.15
- CREON (Drug) $278.78
- Linzess (Drug) $274.38
- ZENPEP (Drug) $266.63
- HUMIRA (Biological) $265.94
- XELJANZ (Drug) $229.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Glendale
Richard Manch, M.d, M.D
Gastroenterology — Payments: $630,233
Gastroenterology $630,233
Frederick Boghossian, M.d, M.D
Gastroenterology — Payments: $175,402
Gastroenterology $175,402
Armine Sarkisian, M.d, M.D
Gastroenterology — Payments: $124,705
Gastroenterology $124,705
Mr. James Tabibian, M.d, M.D
Gastroenterology — Payments: $39,283
Gastroenterology $39,283
Dr. Rimma Shaposhnikov, M.d, M.D
Gastroenterology — Payments: $23,780
Gastroenterology $23,780
Dr. Mehdi Khorsandi, M.d, M.D
Gastroenterology — Payments: $20,237
Gastroenterology $20,237